A 32-year-old woman at 8 weeks of gestation presents with severe nausea and vomiting. She has been unable to tolerate oral intake for 3 days and has lost 2 kg. Her serum electrolytes show mild hypokalemia and hypochloremia. She is concerned about medication use during early pregnancy. Which of the following antiemetics is most appropriate and safest to prescribe?

Explanation

## Clinical Context This patient has hyperemesis gravidarum at 8 weeks gestation (first trimester) with electrolyte disturbances. The question asks for the safest antiemetic with the best safety profile in early pregnancy. ## Why Metoclopramide Is Correct **Key Point:** Metoclopramide is a well-established first-line antiemetic in pregnancy, particularly in the first trimester, with an excellent safety record across all trimesters. **High-Yield:** Metoclopramide is preferred in pregnancy because: 1. **FDA Category B drug** — animal studies show no fetal risk; large human observational studies confirm no teratogenic effects in any trimester 2. Long safety record with millions of exposures in pregnancy worldwide 3. Effective for hyperemesis gravidarum and delayed gastric emptying 4. Does not impair placental perfusion 5. Safe in breastfeeding 6. Endorsed as first-line by multiple obstetric guidelines (ACOG, RCOG) **Clinical Pearl:** Metoclopramide works via central and peripheral dopamine (D2) antagonism and enhances gastric motility, making it ideal for both nausea and the gastroparesis component of hyperemesis gravidarum. ## Antiemetics in Pregnancy: Comparative Safety | Drug | FDA Category | Trimester Safety | Mechanism | Notes | |---|---|---|---|---| | **Metoclopramide** | **B** | All safe | D2 antagonist + prokinetic | **First-line choice** | | **Ondansetron** | B | All safe | 5-HT3 antagonist | Second-line; safe but some data suggest minor cardiac septal defect risk in 1st trimester at high doses | | **Prochlorperazine** | C | Avoid 1st trimester | Phenothiazine | Risk of cleft palate in 1st trimester | | **Domperidone** | C | Avoid 1st trimester | D2 antagonist (peripheral) | Limited safety data; not preferred in pregnancy | | **Promethazine** | C | Avoid 1st trimester | H1 antagonist + anticholinergic | Teratogenic risk in 1st trimester | | **Ginger** | N/A | All safe | Natural remedy | Mild effect; safe adjunct | **Warning:** Phenothiazines (prochlorperazine, promethazine) carry teratogenic risk in the first trimester, particularly cleft palate. Avoid in early pregnancy. ## Why Other Options Are Less Appropriate - **Ondansetron (C):** FDA Category B and widely used, but some meta-analyses (Huybrechts et al., NEJM 2016) raised a signal for minor cardiac septal defects with first-trimester exposure; therefore it is considered second-line after metoclopramide in most guidelines. - **Domperidone (B):** Peripheral D2 antagonist with limited pregnancy safety data; classified Category C and not recommended as first-line. - **Prochlorperazine (D):** Phenothiazine, Category C; associated with cleft palate risk in the first trimester — contraindicated in this scenario. ## First-Trimester Antiemetic Management ``` Nausea/vomiting in 1st trimester ↓ Mild → Ginger, pyridoxine (B6), dietary measures ↓ Moderate → Metoclopramide 10 mg TDS (oral) ↓ Severe/Hyperemesis → Metoclopramide IV/IM + IV fluids + electrolyte correction ↓ No response → Add ondansetron 4–8 mg Avoid: Phenothiazines, Domperidone in 1st trimester ``` **Additional Management:** In hyperemesis gravidarum, IV fluid resuscitation with electrolyte correction (KCl for hypokalemia, NaCl for hypochloremia) is essential alongside antiemetics. [cite: KD Tripathi Essentials of Medical Pharmacology 8e, Ch 16; Harrison's Principles of Internal Medicine 21e, Ch 384; ACOG Practice Bulletin No. 189 — Nausea and Vomiting of Pregnancy]